Back to search

Phase 3, multicenter, randomized, double-blind, placebo-controlled trial of SU11248 in patients (pts) following failure of imatinib for metastatic GIST

Data up to Jan 2025

Published2005
Citations119
References0

Total Citations Per Year

Abstract

References (0)

No references found

Cited By (0)

Loading...
Phase 3, multicenter, randomized, double-blind, placebo-controlled trial of SU11248 in… (2005) – Journal of Clinical Oncology | Metascience Observatory Explorer